NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Rubicon Research Q3 Net Profit Jumps 91% YoY to ₹728 Million; Revenue Up 52%
Rubicon Research reported a strong performance for the quarter ended December 31, 2025, with consolidated revenue growing 51.7% YoY to ₹4,755.29 million. Net profit surged by 91.2% YoY to ₹727.97 million, driven by robust operational growth despite a significant increase in R&D spending, which nearly doubled to ₹535.94 million. For the nine-month period, the company has already surpassed its full-year FY25 profit, reaching ₹1,699.50 million. Investors should note a post-quarter GST inspection mentioned in the auditor's report, though it has not yet impacted the financial results.
முக்கிய அம்சங்கள்
Consolidated Revenue from operations rose 51.7% YoY to ₹4,755.29 million in Q3 FY26.Net Profit after tax saw a massive jump of 91.2% YoY, reaching ₹727.97 million.Research and Development (R&D) expenditure increased significantly to ₹535.94 million from ₹269.30 million YoY.Basic Earnings Per Share (EPS) improved to ₹4.46 in Q3 FY26 compared to ₹2.50 in the same quarter last year.Nine-month FY26 net profit of ₹1,699.50 million has already exceeded the full-year FY25 profit of ₹1,343.61 million.
👀 கவனிக்க வேண்டியவை
The company shows exceptional growth momentum and high R&D focus, making it a strong growth play in the pharma space. Investors should monitor the outcome of the GST inspection mentioned in the auditor's notes for any potential liabilities.
Birla Corp Q3 FY '26: Premium Cement Mix Hits 63% as Mukutban Plant Ramps Up
Birla Corporation Limited reported a strategic focus on trade segments and premium products during its Q3 FY '26 earnings call. Premium cement sales reached 63% of total volume, helping maintain realizations despite heavy competition in the non-trade sector. The Mukutban plant showed significant operational improvement, contributing 6.3 lakh tonnes to the quarterly volume. Management also highlighted a reduced lead distance of 328 kilometers and a consolidated clinker-to-cement ratio of 1.6.
முக்கிய அம்சங்கள்
Premium cement sales increased to 63% of total volume during the quarter.Mukutban plant achieved a volume of 6.3 lakh tonnes with a CC ratio of 0.61.Logistics efficiency improved with the average lead distance reduced to 328 kilometers.Management tenures for the MD & CEO and Chief Marketing Officer were extended by the Board.Company maintained a high trade-segment focus despite non-trade volumes growing nearly 99% in Bihar.
👀 கவனிக்க வேண்டியவை
Investors should focus on the company's ability to sustain premium pricing and the continued margin improvement from the Mukutban plant's ramp-up. The shift toward high-margin trade sales positions the company well against industry-wide pricing pressure in the non-trade segment.
MobiKwik Turns PAT Profitable in Q3 FY26 with ₹40 Mn Profit; Payments GMV Up 63% YoY
One MobiKwik Systems Limited achieved a significant milestone by turning PAT profitable in Q3 FY26, reporting a profit of ₹40 Mn compared to a loss of ₹553 Mn in the previous year. The company's Payments GMV reached an all-time high of ₹481 Bn, driven by a 3.2x surge in UPI transactions and a 63% YoY growth. Financial Services showed robust recovery with ZIP EMI GMV growing 126% YoY to ₹9,000 Mn and gross profit in this segment jumping 405% YoY. With a strong unencumbered cash balance of ₹4,244 Mn and improving margins, the company is now focusing on merchant acquiring as its next major growth lever.
முக்கிய அம்சங்கள்
Turned PAT profitable with ₹40 Mn in Q3 FY26, representing a ₹593 Mn swing from the ₹553 Mn loss in Q3 FY25.Payments GMV hit a record ₹481 Bn, growing 63% YoY, with UPI transactions growing 3.2x YoY.Financial Services (Lending) GMV reached an all-time high of ₹9,000 Mn, up 126% YoY, with net margins improving to 4.13%.EBITDA stood at ₹150 Mn (5% margin) against a loss of ₹427 Mn in the same quarter last year.Maintains a strong liquidity position with ₹4,244 Mn in unencumbered cash and minimal long-term debt.
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive turning point as the company demonstrates a clear path to sustainable profitability while maintaining high growth. Key metrics to watch include the successful scale-up of the merchant acquiring business and the continued stability of credit quality in the lending portfolio.
MobiKwik Turns PAT Profitable in Q3 FY26 with INR 593 Mn YoY Upswing
MobiKwik achieved a major milestone by turning PAT profitable in Q3 FY26, reporting a profit of INR 40 Mn against a loss of INR 553 Mn in the same quarter last year. Revenue grew 8% YoY to INR 2,972 Mn, while EBITDA saw a sharp turnaround to INR 150 Mn from a loss of INR 427 Mn. The performance was driven by a 63% YoY surge in Payments GMV to INR 481 billion and a 126% YoY jump in ZIP EMI (lending) GMV to INR 9,000 Mn. Operating efficiency improved as fixed costs as a percentage of total income fell from 42% to 38%.
முக்கிய அம்சங்கள்
Reported PAT of INR 40 Mn, marking a INR 593 Mn positive swing YoYEBITDA turned positive at INR 150 Mn compared to a loss of INR 427 Mn in Q3 FY25Payments GMV hit an all-time high of INR 481 billion, growing 63% YoYZIP EMI GMV (Lending) grew 126% YoY to INR 9,000 Mn, surpassing previous peaksContribution profit rose 76% YoY to INR 1,288 Mn, driven by a 37% gross margin in payments
👀 கவனிக்க வேண்டியவை
MobiKwik's transition to profitability marks a significant inflection point for the fintech firm. Investors should monitor the sustainability of these margins and the continued scaling of the high-margin lending business.
Bikaji Foods reported a strong Q3 FY26 with revenue growth of 11% and a significant 77% YoY increase in EBITDA, supported by operational efficiencies and stable gross margins of 35%. While the sweets segment saw negative growth due to the early timing of Diwali, core ethnic and western snacks grew by 13.5% and 20% respectively. The company is expanding its footprint with a 1.4 million outlet reach and strategic investments in Hazelnut Factory, increasing its stake to 48%. Management remains optimistic about a 14-16% growth trajectory in core categories driven by GST benefits and demand recovery.
முக்கிய அம்சங்கள்
EBITDA grew 77% YoY in Q3 FY26, with 9-month EBITDA margins standing at 14.2%Core ethnic snacks and western snacks segments recorded growth of 13.5% and 20% respectivelyTotal distribution reach expanded to 1.4 million outlets, with direct reach hitting 3.35 lakh outletsStrategic investment of 40 crore additional capital in Hazelnut Factory to increase stake to 48%Retail business delivered 47 crore revenue from 23 stores, with plans to add 10 more stores next year
👀 கவனிக்க வேண்டியவை
Investors should monitor the scaling of the new bakery JV and the impact of regional marketing campaigns in UP. The stock remains a strong play on the organized snacks market given the robust EBITDA growth and stable margins.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Hester Biosciences Q3 FY26: PAT Surges 140% YoY; H9N2 Vaccine License Received
Hester Biosciences reported a strong 140% YoY increase in standalone PAT for Q3 FY26, driven by a favorable product mix and cost discipline. While the Poultry Healthcare division grew by 32% in Q3, the Animal Healthcare division saw a 38% decline due to timing delays in government-led immunization programs. The company achieved a major regulatory milestone by receiving manufacturing licenses for the H9N2 Avian Influenza vaccine and successfully capitalized its fill/finish facility, doubling its drug product capacity.
முக்கிய அம்சங்கள்
Standalone PAT increased by 140% YoY in Q3 FY26, supported by improved operational discipline.Poultry Healthcare division revenue grew 32% in Q3 and 17% over the 9-month period.Received marketing and manufacturing licenses for the H9N2 Avian Influenza vaccine post-quarter end.Capitalized a new fill/finish facility from the INR 182 crore CWIP, doubling drug product capacity.Animal Healthcare revenue declined 38% in Q3 due to tender delays, with recovery expected in Q4 FY26.
👀 கவனிக்க வேண்டியவை
Investors should focus on the upcoming launch of the H9N2 vaccine and the resumption of government immunization tenders in Q4. The doubling of manufacturing capacity positions the company for significant scale-up in both domestic and export markets.
IFB Industries Q3 FY26 Investor Presentation: Front Loaders Lead Revenue at 34%
IFB Industries has released its investor presentation for the quarter and nine months ended December 31, 2025. The company's revenue mix is dominated by Front Loaders at 34%, followed by Service revenue at 16% and Top Loaders at 15%. Management highlighted that the After Market division, which previously faced material availability issues due to BIS restrictions, has now stabilized. A conference call to discuss these financial results is scheduled for February 4, 2026.
முக்கிய அம்சங்கள்
Front Loaders are the primary revenue driver, contributing 34% to the net sales mix.Service revenue, including AMC and Extended Warranty, accounts for a significant 16% of the total.Air Conditioning (AC) and Top Loader segments contribute 14% and 15% respectively.Management confirmed that material availability issues in the After Market division due to BIS restrictions have stabilized.Investor conference call is scheduled for February 4, 2026, at 4:00 PM IST.
👀 கவனிக்க வேண்டியவை
Investors should attend the February 4th call to understand the margin trajectory and the growth outlook for the AC and Refrigerator segments. Monitor the stabilization of the After Market division as it could improve overall profitability.
Nath Bio-Genes Q3 Revenue Surges 79% to ₹660 Mn; PAT Up 67% YoY
Nath Bio-Genes reported a robust 79% YoY revenue growth in Q3FY26, reaching ₹660 million, primarily driven by a massive 142% value growth in the Maize segment. While Q3 PAT rose 67% to ₹45 million, EBITDA margins faced pressure, declining to 13% from 20% YoY. For 9MFY26, the company achieved a 23% revenue increase to ₹3,859 million, though PAT growth remained muted at 1%. The company is successfully diversifying its portfolio, with significant volume gains in Cotton (21%), Paddy (8%), and Vegetables (43%).
முக்கிய அம்சங்கள்
Q3FY26 Revenue increased by 79% YoY to ₹660 million; 9MFY26 Revenue up 23% to ₹3,859 million.Maize segment witnessed exceptional growth with volume up 94.77% and value up 141.98% YoY.Q3 EBITDA margin compressed to 13% from 20% YoY, while 9M EBITDA margin stood at 14%.Cotton segment remains the primary driver with 25.26% value growth in the first nine months.Vegetable seeds emerged as a fast-growing segment with a 52.08% increase in value during 9MFY26.
👀 கவனிக்க வேண்டியவை
Investors should cheer the strong top-line growth and diversification into high-value crops like Maize and Vegetables, but should closely monitor the impact of rising costs on EBITDA margins.
Nath Bio-Genes Q3 Standalone PAT Jumps 172% to ₹7.23 Cr; Consolidated Profit Declines
Nath Bio-Genes (India) Limited reported a robust standalone performance for Q3 FY26, with revenue growing 79% YoY to ₹65.96 crore and PAT surging 172% to ₹7.23 crore. However, the consolidated net profit for the quarter fell to ₹1.60 crore from ₹2.65 crore YoY, indicating significant losses or expenses within subsidiaries. For the nine-month period ended December 2025, consolidated revenue stood at ₹383.51 crore, up from ₹312.94 crore. Investors should note a qualified auditor's opinion regarding unassessed liabilities from new Labour Codes and the absence of actuarial valuations for employee benefits.
முக்கிய அம்சங்கள்
Standalone Revenue for Q3 FY26 increased 78.9% YoY to ₹65.96 crore from ₹36.87 crore.Standalone Net Profit for the quarter surged to ₹7.23 crore compared to ₹2.66 crore in the same period last year.Consolidated Net Profit for Q3 FY26 dropped to ₹1.60 crore, down from ₹2.65 crore in Q3 FY25.9M FY26 Consolidated Revenue grew 22.5% YoY to ₹383.51 crore from ₹312.94 crore.Auditors issued a qualified opinion due to the lack of financial impact assessment for new Labour Codes effective Nov 2025.
👀 கவனிக்க வேண்டியவை
Investors should investigate the widening gap between standalone and consolidated profits, as subsidiaries appear to be significantly impacting the bottom line. While standalone growth is strong, the auditor's qualification on labor code liabilities and missing actuarial valuations warrants caution regarding future provisions.
Cantabil Retail Opens 3 New Stores in January 2026; Total Store Count Reaches 651
Cantabil Retail India Limited has successfully added 3 new showrooms to its retail network during the month of January 2026. This expansion brings the company's total store count to 651 outlets across India. The consistent addition of physical stores indicates a steady execution of the company's growth strategy to increase market penetration. Investors should look for the impact of this increased footprint on the upcoming quarterly revenue figures.
முக்கிய அம்சங்கள்
Opened 3 new showrooms/shops across various locations in India during January 2026.The total number of operational showrooms/shops has reached 651.The expansion is part of the company's ongoing retail footprint growth strategy.The update was submitted in compliance with Regulation 30 of SEBI (LODR) Regulations, 2015.
👀 கவனிக்க வேண்டியவை
Investors should view the steady store expansion as a positive sign of business health. Monitor the upcoming quarterly results to ensure that the increase in store count is translating into higher sales and maintaining profitability margins.
Birla Corp Q3 Net Profit Surges 71% to Rs 53 Cr; EBITDA/Ton Rises 23% Despite Lower Revenue
Birla Corporation reported a strong 71% YoY growth in consolidated net profit to Rs 53 crore for Q3 FY26, driven by operational efficiencies and a shift towards premium products. While revenue declined 4% to Rs 2,178 crore due to a 6% drop in cement volumes and soft pricing, EBITDA per ton improved significantly by 23.4% to Rs 702. The company successfully reduced production costs by 4% and increased its renewable energy share to 31%. However, the jute division faced headwinds, reporting a cash loss of Rs 2.14 crore due to high raw material costs.
முக்கிய அம்சங்கள்
Consolidated Net Profit grew 71% YoY to Rs 53 crore; EBITDA rose 18.4% to Rs 312 crore.EBITDA per ton for the cement division increased 23.4% YoY to Rs 702 despite a 4% decline in revenue.Blended cement sales reached 87% of total volume, up from 79% a year ago.Power and fuel costs per ton decreased by 6% YoY, with renewable energy share rising to 31%.Revenue fell 4% to Rs 2,178 crore as cement sales volumes declined 6% to 4.23 million tons.
👀 கவனிக்க வேண்டியவை
Investors should focus on the company's successful margin expansion through cost rationalization and premiumization despite volume pressure. Monitor the recovery in cement demand and the impact of raw jute supply constraints on the jute division's performance.
Birla Corp Q3 Net Profit Rises 69% to ₹52.76 Cr; Extends CMO and HR Head Terms
Birla Corporation reported a strong 69% year-on-year growth in consolidated net profit to ₹52.76 crore for the quarter ended December 2025, despite a slight revenue dip to ₹2,158.74 crore. The company's 9-month performance showed a massive surge in profit to ₹262.81 crore from ₹38.62 crore in the previous year, driven by improved operating margins of 13.65%. In a move to ensure leadership stability, the board extended the terms of Chief Marketing Officer Kalidas Pramanik for two years and Head of HR Rajesh Kakkar for one year. The quarterly results were achieved despite an exceptional loss of ₹34.14 crore.
முக்கிய அம்சங்கள்
Consolidated Net Profit for Q3 FY26 rose 69% YoY to ₹52.76 crore from ₹31.19 crore.9-month Net Profit surged to ₹262.81 crore compared to ₹38.62 crore in the previous year.Operating margins improved to 13.65% in Q3 FY26 from 11.92% in the corresponding quarter last year.CMO Kalidas Pramanik's term extended for 2 years; HR Head Rajesh Kakkar's term extended for 1 year.Revenue from operations for Q3 stood at ₹2,158.74 crore, down slightly from ₹2,256.65 crore YoY.
👀 கவனிக்க வேண்டியவை
Investors should take note of the significant margin expansion and bottom-line growth despite flat revenue, suggesting efficient cost management. The extension of key management personnel ensures continuity in the company's marketing and human resource strategies.
Hester Biosciences Q3 Standalone PAT Jumps 140% to ₹106.7M; Poultry Division Grows 32%
Hester Biosciences reported a robust standalone performance for Q3 FY26, with PAT surging 140% YoY to ₹106.69 million on a 12% revenue increase. The growth was primarily driven by the Poultry Healthcare division, which grew 32%, while the Animal Healthcare division faced a 38% decline due to delayed government tenders. Consolidated PAT for the quarter fell 18% to ₹93.10 million, largely due to losses in the African subsidiary. However, the company has doubled its drug product capacity and expects a strong Q4 as national immunization programs resume.
முக்கிய அம்சங்கள்
Standalone Q3 PAT rose 140% to ₹106.69 million, while standalone revenue grew 12% to ₹703.54 million.Poultry Healthcare division delivered 32% growth in Q3, supported by a new H9N2 Avian Influenza vaccine license.Animal Healthcare revenue declined 38% due to deferred government orders, which are scheduled to commence in February 2026.Consolidated 9M FY26 PAT stands at ₹409.37 million, representing a 50% growth over the previous year.Capitalized a new fill-finish facility during the quarter, effectively doubling the company's drug product capacity.
👀 கவனிக்க வேண்டியவை
Investors should view the standalone margin expansion and poultry segment growth as positive indicators of operational efficiency. The temporary dip in animal healthcare revenue is expected to reverse in Q4, making the current performance a strong base for year-end results.
Hester Biosciences Q3 Standalone PAT Surges 140% YoY to ₹106.7 Mn; CEO Re-appointed
Hester Biosciences delivered a robust standalone performance for Q3 FY26, with Net Profit jumping 140% YoY to ₹106.69 million. Standalone revenue grew by 12% YoY, driven primarily by a 32% growth in the Poultry Healthcare segment. However, consolidated PAT declined by 18% YoY to ₹93.10 million, largely due to a sharp reduction in 'Other Income' compared to the previous year. The board also confirmed the re-appointment of founder Rajiv Gandhi as CEO and Managing Director for a three-year term starting April 2026.
முக்கிய அம்சங்கள்
Standalone Revenue from Operations increased 12% YoY to ₹703.54 million in Q3 FY26.Standalone Net Profit (PAT) rose 140% YoY to ₹106.69 million from ₹44.39 million.Poultry Healthcare segment revenue grew 32% YoY to ₹513.02 million.Consolidated PAT fell 18% YoY to ₹93.10 million, impacted by lower other income of ₹6.69 million vs ₹78.09 million YoY.Mr. Rajiv Gandhi re-appointed as CEO & Managing Director for 3 years effective April 1, 2026.
👀 கவனிக்க வேண்டியவை
Investors should take note of the strong operational recovery in the standalone business and the significant growth in the poultry segment. The re-appointment of the founder-CEO ensures leadership continuity, making the stock a 'Watch' for sustained margin improvement.
A B Infrabuild Secures ₹48.58 Crore Railway Project from East Coast Railways
A B Infrabuild Limited has received a Letter of Acceptance from East Coast Railways for a new infrastructure project. The contract involves the construction of a Road Over Bridge (ROB) and associated works like approach roads and drainage systems in the Khurda Road Division. The total value of the order is approximately ₹48.58 crore, providing significant revenue visibility for the company. The project is scheduled to be completed within a timeframe of 24 months.
முக்கிய அம்சங்கள்
Awarded a contract worth ₹48.58 crore by East Coast Railways, Indian Railways.Project involves construction of a Road Over Bridge (ROB) with composite and T-Beam girders.The scope includes allied works such as approach roads, RE walls, service roads, and drains.The execution period for the entire project is set at 24 months.The project is located between IPM-JPI stations on the KUR-PSA Main Line.
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive development for the company's order book and revenue pipeline. Monitor the company's execution efficiency over the 24-month period to ensure timely completion and margin protection.
Birla Cable Q3 Results: Net Profit Surges 178% YoY to ₹4.02 Cr; Revenue up 30%
Birla Cable reported a strong performance for the quarter ended December 31, 2025, with consolidated revenue from operations growing 29.6% YoY to ₹204.51 crore. Net profit saw a significant jump of 178% YoY to ₹4.02 crore, driven by higher operational scale and a sharp reduction in finance costs. The company's 9-month profit for FY26 reached ₹6.06 crore, already surpassing the full-year profit of FY25. Notably, the bottom line was impacted by a one-time employee benefit expense of ₹2.23 crore due to the implementation of new Labour Codes.
முக்கிய அம்சங்கள்
Revenue from operations grew 29.6% YoY to ₹204.51 crore in Q3 FY26 compared to ₹157.80 crore in Q3 FY25.Consolidated Net Profit increased by 178% YoY to ₹4.02 crore from ₹1.44 crore in the same quarter last year.Finance costs significantly reduced to ₹2.23 crore in Q3 FY26 from ₹3.94 crore in Q3 FY25, indicating improved debt management.9M FY26 Net Profit of ₹6.06 crore has already exceeded the total FY25 annual profit of ₹5.03 crore.Employee expenses include a ₹2.23 crore incremental impact from the new Labour Codes effective November 2025.
👀 கவனிக்க வேண்டியவை
The company shows strong operational recovery and improved profitability through cost control and lower interest burdens. Investors should maintain a positive outlook while monitoring raw material price trends and the full impact of new labor regulations on future margins.
A B Infrabuild Secures ₹51.80 Crore Railway Contract for Road Over Bridge Construction
A B Infrabuild Limited has been awarded a significant domestic contract by East Coast Railways, Indian Railways. The project involves the construction of a Road Over Bridge (ROB) between Sompeta and Baruva Railway Stations under the Khurdha Road Division. Valued at approximately ₹51.80 Crore, this contract strengthens the company's order book in the specialized infrastructure segment. The project is expected to be completed within a 24-month period, providing revenue visibility for the next two fiscal years.
முக்கிய அம்சங்கள்
Awarded a contract worth ₹51,79,91,304 from East Coast RailwaysProject involves construction of a Road Over Bridge (ROB) at Rly km 649/11-13Execution timeline for the entire project is set at 24 monthsTechnical scope includes 1x36.0m and 2x24.0m Composite Girders plus 4x18.75m T-Beam Girders
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive development for the company's order book and monitor the timely execution of the project to ensure margin protection. The 24-month execution window provides steady revenue potential for the mid-term.
Bigbloc Construction Q3 FY26 Revenue Hits Record Rs 728 Mn; Returns to Profitability
Bigbloc Construction reported its highest-ever quarterly revenue of Rs 728 million in Q3 FY26, representing a 28.1% YoY growth driven by a 38% surge in sales volume. The company successfully returned to profitability with a PAT of Rs 4 million, while EBITDA margins expanded to 11.1% due to improved capacity utilization of 67%. Strategic developments include a significant order from Larsen & Toubro and the imminent commencement of commercial production at the Umargaon construction chemicals facility. Management remains optimistic, targeting long-term EBITDA margins of 15-20% as utilization scales further.
முக்கிய அம்சங்கள்
Consolidated revenue reached a record Rs 728 million, growing 28.1% YoY and 8.2% QoQ.Sales volume increased 38% YoY to 2,14,643 cubic meters, with overall capacity utilization rising to 67%.EBITDA grew 31.8% YoY to Rs 81 million, with margins improving to 11.1% from 2.8% in the previous quarter.Secured a major purchase order from Larsen & Toubro (L&T) for AAC blocks, strengthening the institutional order book.Announced expansion plans for a new facility in Madhya Pradesh and the start of construction chemicals production at Umargaon.
👀 கவனிக்க வேண்டியவை
Investors should monitor the ramp-up of the high-margin AAC wall panel segment and the execution of the new MP plant expansion. The sharp margin recovery and return to profitability suggest a positive operational turnaround.
ESAB India to Increase Stake in Sunsure Solar SPV to 17.38% for ₹1.95 Crore
ESAB India Limited has announced an additional equity investment in Sunsure Solar Park Twenty-Four Private Limited, a Special Purpose Vehicle (SPV) for renewable energy. The company is increasing its shareholding from 9.78% to 17.38% with an additional subscription of ₹1.95 crore. This move is part of a group captive power arrangement to secure renewable energy for its manufacturing plants in Tamil Nadu. The total board-approved investment for this project stands at ₹2.12 crore.
முக்கிய அம்சங்கள்
Shareholding in Sunsure Solar SPV to increase from 9.78% to 17.38%Additional cash investment of ₹1,94,78,700 to be made in the SPVTotal investment approved by the Board for this project is ₹2,12,00,000Investment facilitates captive solar power consumption for Tamil Nadu manufacturing unitsThe target SPV was incorporated in April 2024 and is currently pre-operational
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive move towards long-term operational cost reduction and ESG compliance. While the investment amount is relatively small, it secures sustainable energy for core manufacturing operations.
SBI Card Q3 FY26 Results: PAT Surges 45% YoY to ₹557 Cr; Spends Grow 33%
SBI Card reported a strong Q3 FY26 with Profit After Tax (PAT) rising 45% YoY to ₹557 crore, driven by a 12% increase in total revenue and a 5% reduction in finance costs. Total spends witnessed robust growth of 33% YoY, reaching ₹1,14,702 crore, while cards-in-force grew 8% to 2.18 crore. Asset quality showed improvement with Gross NPA declining to 2.86% from 3.24% YoY, although Net NPA rose slightly to 1.28%. The company maintained a healthy capital adequacy ratio of 24.4%, reflecting a strong balance sheet.
முக்கிய அம்சங்கள்
Net Profit increased by 45% YoY to ₹557 Cr, supported by a 7% decrease in impairment costs.Total Spends grew significantly by 33% YoY to ₹1,14,702 Cr, indicating strong consumer transaction volume.Gross NPA improved to 2.86% from 3.24% YoY, while Return on Average Assets (ROAA) expanded to 3.2%.Total Revenue from operations rose 12% YoY to ₹5,353 Cr, with fee-based income growing 17%.Capital Adequacy remains robust at 24.4%, with Tier 1 capital at 19.1%.
👀 கவனிக்க வேண்டியவை
The significant jump in profitability and spend growth makes this a positive result; however, investors should monitor the slowdown in new account acquisitions (864K vs 1,175K YoY) and the slight rise in Net NPA.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
